EJHG series: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C9 and HLA and anti-epileptic drugs

L Manson; M Nijenhuis; B Soree; N de Boer-Veger; AM Buunk; E Houwink; A Risselada; G Rongen; R Van Schaik; J Swen; D Touw; J Van der Weide; R van Westrhenen; V Deneer; HJ Guchelaar

doi:10.1038/s41431-023-01482-x

EJHG series: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C9 and HLA and anti-epileptic drugs

L Manson, M Nijenhuis, B Soree, N de Boer-Veger, AM Buunk, E Houwink, A Risselada, G Rongen, R Van Schaik, J Swen, D Touw, J Van der Weide, R van Westrhenen, V Deneer, HJ Guchelaar

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	683-683
Number of pages	1
Journal	European Journal of Human Genetics
Volume	32
DOIs	https://doi.org/10.1038/s41431-023-01482-x
Publication status	Published - Jan 2024

Access to Document

10.1038/s41431-023-01482-x

Cite this

Manson, L., Nijenhuis, M., Soree, B., de Boer-Veger, N., Buunk, AM., Houwink, E., Risselada, A., Rongen, G., Van Schaik, R., Swen, J., Touw, D., Van der Weide, J., van Westrhenen, R., Deneer, V., & Guchelaar, HJ. (2024). EJHG series: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C9 and HLA and anti-epileptic drugs. European Journal of Human Genetics, 32, 683-683. https://doi.org/10.1038/s41431-023-01482-x

@article{5bbca23845e6472ba58589d8050e93a7,

title = "EJHG series: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C9 and HLA and anti-epileptic drugs",

author = "L Manson and M Nijenhuis and B Soree and {de Boer-Veger}, N and AM Buunk and E Houwink and A Risselada and G Rongen and {Van Schaik}, R and J Swen and D Touw and {Van der Weide}, J and {van Westrhenen}, R and V Deneer and HJ Guchelaar",

year = "2024",

month = jan,

doi = "10.1038/s41431-023-01482-x",

language = "English",

volume = "32",

pages = "683--683",

journal = "European Journal of Human Genetics",

issn = "1018-4813",

publisher = "Springer Nature",

}

Manson, L, Nijenhuis, M, Soree, B, de Boer-Veger, N, Buunk, AM, Houwink, E, Risselada, A, Rongen, G, Van Schaik, R, Swen, J, Touw, D, Van der Weide, J, van Westrhenen, R, Deneer, V & Guchelaar, HJ 2024, 'EJHG series: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C9 and HLA and anti-epileptic drugs', European Journal of Human Genetics, vol. 32, pp. 683-683. https://doi.org/10.1038/s41431-023-01482-x

TY - JOUR

T1 - EJHG series

T2 - Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C9 and HLA and anti-epileptic drugs

AU - Manson, L

AU - Nijenhuis, M

AU - Soree, B

AU - de Boer-Veger, N

AU - Buunk, AM

AU - Houwink, E

AU - Risselada, A

AU - Rongen, G

AU - Van Schaik, R

AU - Swen, J

AU - Touw, D

AU - Van der Weide, J

AU - van Westrhenen, R

AU - Deneer, V

AU - Guchelaar, HJ

PY - 2024/1

Y1 - 2024/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=d7dz6a2i7wiom976oc9ff2iqvdhv8k5x&SrcAuth=WosAPI&KeyUT=WOS:001147414903313&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1038/s41431-023-01482-x

DO - 10.1038/s41431-023-01482-x

M3 - Meeting Abstract

SN - 1018-4813

VL - 32

SP - 683

EP - 683

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

ER -